N
TLSI icon

Nuveen’s TriSalus Life Sciences TLSI Stock Holding History

Nuveen’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$146K Hold
36,550
– – ﹤0.01% 3149
2025
Q4 		$255K Buy
36,550
+15,956
+77% +$89.3K ﹤0.01% 3087
2025
Q3 		$95.8K Hold
20,594
– – ﹤0.01% 3225
2025
Q2 		$112K Buy
+20,594
New +$110K ﹤0.01% 3242

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Nuveen's TLSI Position: Q1 2026 in Review

Nuveen held its TriSalus Life Sciences (TLSI) position steady in Q1 2026 at 36,550 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #3149.

Nuveen first reported a position in TLSI in Q2 2025 and has held it in 4 quarters since. The position peaked at $255K in Q4 2025. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Nuveen held 36,550 shares of TriSalus Life Sciences worth $146K as of Q1 2026.
  • Nuveen left its TriSalus Life Sciences share count unchanged in Q1 2026.
  • TriSalus Life Sciences made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #3149 holding.
  • Nuveen first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • Nuveen's TriSalus Life Sciences position peaked at $255K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.